LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration

LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration

Abstract Introduction Photobiomodulation (PBM) represents a potential treatment for non-exudative age-related macular degeneration (AMD). PBM uses wavelengths of light to target components of the mitochondrial respiratory chain to improve cellular bioenergetic outputs. The aim of this study was to f...

Full description

Bibliographic Details
Main Authors: Ben Burton, Maurizio Battaglia Parodi, Ignasi Jürgens, Xavier Zanlonghi, Dan Hornan, Johann Roider, Katrin Lorenz, Marion R. Munk, Cindy L. Croissant, Stephanie E. Tedford, Michael Walker, Rene Ruckert, Clark E. Tedford
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-01-01
Series:Ophthalmology and Therapy
Subjects:
Photobiomodulation
Multiwavelength
Age related macular degeneration
Mitochondria
Ocular disease
Vision
Online Access:https://doi.org/10.1007/s40123-022-00640-6

Internet

https://doi.org/10.1007/s40123-022-00640-6

Similar Items